The colors on a PET scan represent how much of a radioactive tracer a given area of the body has absorbed, with brighter or “hotter” colors indicating higher tracer uptake and cooler colors indicating lower uptake. There is no single universal color scheme: most clinical PET images use either a grayscale, a “hot body” scale running from black through red and yellow to white, or a rainbow scale where blue marks the lowest activity and red or white marks the highest. The colors are not photographs of tissue; they are a visual translation of metabolic activity, and understanding what drives that activity is the key to reading what the colors actually mean.
How the Tracer Creates the Image
The vast majority of PET scans use a tracer called FDG, a modified sugar molecule tagged with a small amount of radioactive fluorine. After injection, FDG enters cells the same way normal glucose does, carried by glucose transporter proteins on the cell surface. Once inside, the cell’s enzymes begin to process it, but FDG gets stuck partway through the metabolic pathway. It becomes trapped inside the cell, accumulating there and emitting tiny positron particles that the scanner detects.1PubMed. FDG accumulation and tumor biology The scanner records where those emissions originate, and software converts the raw detection data into an image. Regions that consumed more FDG light up more intensely. Regions that consumed less appear dimmer.
This is why cancer cells tend to stand out. Tumor cells consume glucose at a much higher rate than most healthy tissues, a metabolic quirk that has been exploited in PET imaging for decades.2PubMed Central. PET Metabolic Biomarkers for Cancer The brighter a spot appears on the scan, the more aggressively that tissue was pulling in sugar. But cancer is not the only thing that consumes glucose eagerly, and that distinction matters more than most patients realize.
What the Colors Actually Represent
When you look at a PET image, you are looking at a map of metabolic intensity, not a direct picture of anatomy. The software assigns colors based on the number of detected emissions in each tiny volume element (called a voxel) of the image. The color scale the software uses is a display choice, not a physical property of the tissue. A radiologist can switch the same scan from a rainbow palette to grayscale or a “hot iron” palette with a click. None of these change the underlying data; they change how your eyes perceive contrast.
In practice, most oncology PET scans use a hot-body scale. In this scheme, black means virtually no tracer uptake, dark reds and oranges indicate moderate uptake, bright yellow signals high uptake, and white marks the most intense activity. Some centers use an inverted grayscale where the brightest white areas are the hottest. Rainbow scales, where blue is cold and red is hot, are more common in research and in brain imaging. The choice of scale can actually affect how clearly a lesion stands out from surrounding tissue, which is why radiologists sometimes toggle between scales when reading the same scan.
The numeric value behind the color is usually expressed as a standardized uptake value, or SUV. An SUV of 1.0 means the tissue absorbed tracer at roughly the average rate you would expect if it were distributed evenly throughout the body. A much higher SUV indicates a tissue pulling in far more tracer than average. In oncology, an SUV above about 2.5 is often used as a rough threshold to flag suspicious areas, though the exact cutoff depends on the type of cancer, the organ involved, and institutional practice. Camera resolution, the mathematical method used to reconstruct the image, and even the smoothing filters applied can all shift the maximum voxel value in a given region, which in turn affects any threshold-based interpretation.3PubMed Central. What Is the Best Way to Contour Lung Tumors on PET Scans: Multi-Observer Validation of a Gradient-Based Method Using a NSCLC Digital PET Phantom – Section: DISCUSSION This is one reason why reading PET scans is as much art as science: the raw data are quantitative, but the visual display involves choices that can subtly shape perception.
Why Some Normal Organs Light Up
One of the most common sources of confusion when patients see their own PET images is the amount of “hot” color in areas that are perfectly healthy. The brain, for instance, is the body’s most prolific glucose consumer, so it almost always glows intensely on an FDG-PET scan. The heart muscle, particularly when it has been feeding on glucose rather than fatty acids, can light up brightly. The liver, kidneys, and bladder routinely show significant uptake because the tracer is filtered and excreted through these organs. Skeletal muscle that was recently active can absorb extra tracer, and even the gut wall sometimes shows patchy uptake from normal digestive activity.
Research mapping FDG uptake across 13 body regions in healthy adults confirmed that organs like the brain, heart, liver, kidneys, and colon all show characteristic uptake patterns, and that the variation in these normal values is relatively consistent from person to person.4PubMed Central. Normal values for (18)F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patients Radiologists learn these normal patterns thoroughly. When they read a scan, they are looking for uptake that exceeds or deviates from these expected baselines, not simply for any area that “lights up.”
Blood glucose levels at the time of the scan also influence the picture. Since FDG and regular glucose compete for the same cellular transporters, high blood sugar can reduce how much FDG gets into cells, effectively dimming the image. In the brain specifically, elevated blood glucose has been shown to decrease FDG uptake because the transporters are already saturated with regular glucose.5PubMed Central. Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review – Section: Discussion This is why patients are told to fast before a PET scan and why diabetic patients sometimes need special preparation: an unreliable glucose environment produces an unreliable image.
False Positives and What Else Lights Up
The single biggest limitation of FDG-PET is that the tracer is not cancer-specific. Anything that drives cells to consume more glucose will create a bright signal. Infections caused by bacteria, fungi, or tuberculosis can produce intense uptake that mimics a tumor. Sarcoidosis, an inflammatory condition, lights up reliably. Radiation pneumonitis (lung inflammation after radiation therapy) and healing surgical sites can all glow hot enough to fool a threshold-based reading.6PubMed Central. False positive and false negative FDG-PET scans in various thoracic diseases
False negatives also occur. Some cancers are slow-growing and metabolically quiet, meaning they do not consume enough glucose to register above background. Certain types of prostate cancer, well-differentiated thyroid cancer, and some low-grade lymphomas fall into this category. A “cold” spot on a PET scan does not guarantee the absence of disease any more than a “hot” spot guarantees its presence.
This is why PET scans are almost never interpreted in isolation. The colors tell a metabolic story, but a radiologist reads that story alongside the patient’s clinical history, lab results, and anatomical imaging. A bright spot in the lung of a patient with a known fungal infection carries a completely different weight than the same bright spot in a patient with a history of lung cancer.
Why PET Is Almost Always Paired With CT
If you have had a PET scan in the past two decades, it was almost certainly a PET/CT, meaning the scanner acquired both a PET image and a CT image during the same session. The CT provides the anatomical detail that PET lacks: precise bone structure, organ boundaries, and tissue density. The PET provides the metabolic information that CT cannot show. Fusing the two gives radiologists a composite image where they can see not just that something is metabolically active, but exactly where it sits in the body.
The CT data also serve a technical purpose. The PET scanner needs to correct for the fact that positron emissions from deep inside the body are partially absorbed by surrounding tissue before they reach the detector ring. CT images provide a map of tissue density that the software uses to apply these corrections, making the PET signal more accurate.7PubMed. A combined PET/CT scanner for clinical oncology Without this step, structures deep in the chest or abdomen would appear artificially dim compared to superficial structures.
On the display screen, radiologists typically toggle between three views: the PET image alone (the color map), the CT image alone (the familiar gray anatomy), and the fused overlay where the PET colors are layered on top of the CT anatomy. The fusion view is where the diagnostic magic happens. A hot spot that floats in empty space on the PET-only view suddenly localizes to a specific lymph node, a bone lesion, or a segment of bowel when the CT anatomy is brought in.
More recently, PET/MRI scanners have entered clinical use, particularly for brain and pediatric imaging, where the superior soft-tissue contrast of MRI adds value. Research is also exploring ways to reduce the radiation dose from the CT component, including using deep-learning algorithms that can generate attenuation correction maps from much lower-dose scans.8PubMed Central. Dual‐view scout scans with deep learning for ultra‐low dose attenuation correction in PET
Reading PET Scans of the Brain
Brain PET imaging flips the interpretive logic. In oncology, you are looking for areas that are abnormally bright. In neurology, particularly when evaluating dementia, you are often looking for areas that are abnormally dim. A healthy brain consumes glucose voraciously and should glow fairly uniformly across its cortex. When regions of the brain show reduced FDG uptake compared to what is expected, it suggests those neurons are underperforming or dying.
In Alzheimer’s disease, the pattern of reduced uptake tends to appear in the temporal and parietal lobes of the brain, regions involved in memory and spatial processing. This hypometabolic signature can appear years before a clinical diagnosis. Research has found that people with severe glucose hypometabolism in the brain had a dramatically accelerated rate of cognitive decline compared to those with preserved metabolism, with the progression rate roughly seven times faster in the most affected group.9PubMed Central. FDG-PET brain glucose hypometabolism predicts Alzheimer’s disease progression pathways in cognitively normal adults: A longitudinal competing risks modeling – Section: RESULTS
Other neurological conditions produce distinct patterns. Delirium, for example, can also cause reduced brain metabolism, but the affected regions are different. Thalamic hypometabolism, a finding atypical of Alzheimer’s, has been identified as a distinguishing feature of delirium.10PubMed Central. Regional cerebral hypometabolism on 18F‐FDG PET/CT scan in delirium is independent of acute illness and dementia – Section: Discussion Frontotemporal dementia produces a different pattern still, with the frontal lobes going dark while the posterior brain remains relatively preserved. A trained reader can often distinguish between these conditions based on which regions are “cold” and which are not, turning the color map into a diagnostic fingerprint.
Reading PET Scans of the Heart
Cardiac PET adds yet another interpretive layer. The heart muscle can switch between burning fatty acids and burning glucose depending on its metabolic state, so cardiac PET protocols deliberately manipulate which fuel the heart is using. For viability imaging, where the question is whether a region of heart muscle is alive but underperfused (and therefore salvageable with a procedure) or truly dead, the scan looks for a specific pattern called a perfusion-metabolism mismatch.
Here is how it works in practice: a separate perfusion scan (sometimes using a different tracer) shows which areas of the heart are receiving inadequate blood flow. Then the FDG-PET shows which areas are metabolically active. If a segment has poor blood flow but still absorbs FDG, the muscle is alive and “hibernating,” waiting for better circulation. This mismatch pattern is associated with significant improvement in heart function after revascularization.11PubMed Central. Fluorodeoxyglucose Applications in Cardiac PET: Viability, Inflammation, Infection, and Beyond If a segment has poor blood flow and also shows no FDG uptake, the tissue is likely scarred and dead, and restoring blood flow will not help. In one study of 59 patients undergoing viability assessment, about three-quarters showed mismatch patterns indicating viable myocardium.12Journal of Nuclear Medicine. 18F-FDG PET in Myocardial Viability Assessment: A Practical and Time-Efficient Protocol
Cardiac PET is also used to detect inflammation in the heart from conditions like sarcoidosis or endocarditis, where focal bright spots in the myocardium signal active inflammatory or infectious processes. The preparation protocol matters enormously here: the patient must fast long enough for the heart to switch from glucose to fatty acid metabolism, so that any remaining FDG uptake in the heart stands out as abnormal. If the preparation fails and the heart is still burning glucose, the entire myocardium lights up and masks the pathology.
Beyond FDG: Tracers That Target Different Biology
FDG is the workhorse, but it is not the only tracer in use. Specialized tracers are designed to bind to specific molecular targets, and each produces its own color map reflecting that target’s distribution. One widely used example targets a protein called PSMA, which is overexpressed on the surface of most prostate cancer cells. PSMA-PET scans use tracers tagged with gallium-68 or fluorine-18 that bind directly to this protein, producing a signal that is far more specific to prostate cancer than FDG would be.
Research comparing PSMA-PET signals against histological analysis of prostate tissue has shown a significant correlation between the intensity of the PET signal and the actual amount of PSMA protein expressed in the tumor. Areas with strong PSMA expression overlapped substantially more with the bright regions on the PET scan than areas with low expression.13Springer Link (Eur J Nucl Med Mol Imaging). Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 This means the color map on a PSMA-PET scan is not showing glucose consumption; it is showing where the cancer’s surface marker is densest. The interpretive framework shifts accordingly: a bright spot indicates high PSMA expression, not necessarily high metabolic rate.
Other tracers target amino acid transport (useful for brain tumors, where normal brain glucose uptake makes FDG less helpful), bone metabolism (for detecting skeletal metastases), and cell proliferation. Each tracer tells a different biological story, and the colors on the resulting scan reflect that specific story. If you are shown PET images from different tracers, the “hot” spots may not overlap at all, because each tracer is measuring a different biological process.
How Thresholds and Display Settings Shape What You See
A PET scan that looks alarming on screen might look unremarkable with different display settings, and this is not a flaw but a feature of how the technology works. Radiologists adjust the “window” and “level” of the color display, compressing or expanding the range of values that get mapped to visible colors. A narrow window exaggerates contrast, making subtle differences pop but potentially making moderate uptake look dramatically hot. A wide window smooths everything out, potentially hiding small lesions in the noise.
This matters practically when PET images are used to plan radiation therapy. Radiation oncologists sometimes draw the borders of a tumor based on a threshold percentage of the maximum SUV. One study found that using a threshold of 40% of the maximum SUV produced tumor volumes that were significantly smaller than those drawn on CT alone, and different from volumes defined by an absolute SUV cutoff of 2.5.14PubMed. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning – Section: RESULTS The choice of threshold literally changes the size of the area treated with radiation, which affects both tumor control and side effects. Gradient-based methods that look at how sharply the signal drops off at a tumor’s edge, rather than relying on a fixed percentage, are less affected by changes in the maximum signal and may produce more consistent contours.3PubMed Central. What Is the Best Way to Contour Lung Tumors on PET Scans: Multi-Observer Validation of a Gradient-Based Method Using a NSCLC Digital PET Phantom – Section: DISCUSSION
If you are a patient reviewing your own scan images on a portal or printed report, keep this in mind: the dramatic red-and-yellow blobs you see are a visualization of data, shaped by display settings chosen for clinical utility. Two images of the same scan can look strikingly different depending on the color scale and the window used. This is not evidence of error; it is why trained readers interpret PET scans rather than the images speaking for themselves.
Beyond SUV: Newer Quantitative Approaches
The standard SUV is a snapshot, a single number from a single moment. But tracer behavior is dynamic: it enters the bloodstream, gets taken up by tissue at varying rates, gets metabolized, and eventually washes out. Kinetic analysis captures this entire time course by taking multiple measurements as the tracer distributes, producing parameters that describe how fast tissue absorbs the tracer, how efficiently it gets trapped, and how quickly it washes back out. These dynamic parameters can provide physiologically richer information than a static SUV alone.15PubMed Central. Comprehensive Insights into Total Body Pet: Physics, Systems and Clinical Applications: Reviews
Total-body PET scanners, which cover the entire body in a single detector ring rather than imaging one slice at a time, have made kinetic analysis more practical. They can capture dynamic data from all organs simultaneously, something older scanners could not do. This opens the door to parametric images, where instead of mapping raw tracer concentration, each voxel’s color represents a kinetic parameter like the rate of glucose metabolism. These parametric maps can improve contrast between tumor and background tissue, potentially making small or subtle lesions easier to spot.
Machine learning and deep learning are also reshaping PET image quality. Algorithms trained on large datasets can take images acquired with a fraction of the normal tracer dose and reconstruct them to approach the quality of full-dose scans. In testing, AI-reconstructed images from scans using only about 6% of the standard dose showed statistically significant improvements in image quality compared to the raw low-dose images.16PubMed Central. Low-Count Whole-Body PET/MRI Reconstruction: An Evaluation of Dose Reduction Spectrum and Five State-of-the-Art Artificial Intelligence Algorithms – Section: Results This matters directly for patients, because less tracer means less radiation exposure. Deep learning methods are being integrated into reconstruction and post-processing pipelines across the field, with applications ranging from noise reduction to resolution enhancement.17PubMed Central. Deep learning-based image reconstruction and post-processing methods in positron emission tomography for low-dose imaging and resolution enhancement
What Patients Should and Should Not Try to Read Themselves
Patient portals increasingly provide direct access to imaging, and it is natural to want to interpret what you see. Some aspects of a PET scan are reasonably intuitive once you know the basics: the brain and bladder will be bright, both kidneys should look roughly symmetrical, and the liver provides a fairly uniform baseline. If your scan was done for cancer staging, the report will note any focal areas of increased uptake and their SUV values, and compare them to background references like the liver or blood pool.
What patients consistently underestimate is how much context shapes interpretation. A mildly bright lymph node in the neck of a 25-year-old who recently had a cold means something entirely different from the same finding in a 65-year-old with a history of lymphoma. The SUV number alone does not make the diagnosis. The location, shape, symmetry, relationship to known anatomy, clinical history, and comparison to prior scans all factor in. Radiologists spend years learning to integrate these layers, and even experienced readers sometimes disagree on borderline cases.
If you are looking at your own scan, here is what is worth noticing: whether the report describes uptake as “focal” (concentrated in one spot) versus “diffuse” (spread out), whether the SUV is described as mild, moderate, or intense, and whether the interpreting physician recommends follow-up imaging or biopsy. The colors themselves are less informative than the narrative the radiologist builds around them. A scan covered in alarming-looking warm colors may be entirely normal, and a scan that looks mostly dark may still contain a small, significant finding buried in the data.